Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multi-centre Prospective Non-interventional Study Investigating the Clinical Effectiveness of Ryzodeg (Insulin Degludec/Insulin Aspart) in Patients With Type 2 Diabetes Mellitus in a Real-world Setting

Next Previous
Search
Trial Profile

A Multi-centre Prospective Non-interventional Study Investigating the Clinical Effectiveness of Ryzodeg (Insulin Degludec/Insulin Aspart) in Patients With Type 2 Diabetes Mellitus in a Real-world Setting

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Sep 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Insulin degludec/insulin aspart (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms ARISE
  • Sponsors Novo Nordisk

    • Most Recent Events

    • 25 Jun 2022 Results published in the Advances in Therapy
    • 18 May 2022 Primary endpoint (Change in local laboratory measured glycosylated haemoglobin (HbA1c)) has been met as per results presented at the 27th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
    • 18 May 2022 Results of an analysis assessed the impact of insulin degludec/insulin aspart (IDegAsp) treatment on healthcare resource utilization presented at the 27th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top